Today: March 25, 2017, 8:50 am

New Market Report Now Available: Hairy Cell Leukemia Global Clinical Trials Review, H1, 2014

Recently published research from GlobalData, "Hairy Cell Leukemia Global Clinical Trials Review, H1, 2014", is now available at Fast Market Research 2014-03-20 00:25:17
GlobalData's clinical trial report, "Hairy Cell Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Hairy Cell Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hairy Cell Leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hairy Cell Leukemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Full Report Details at
- ..

Report Scope

* Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
* Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
* Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to Get this Report

* Understand the dynamics of a particular indication in a condensed manner
* Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
* Obtain discontinued trial listing for trials across the globe
* Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Partial Table of Contents:

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hairy Cell Leukemia 6
Symptoms of HCL are: 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Hairy Cell Leukemia to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Hairy Cell Leukemia 20
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Hairy Cell Leukemia Therapeutics Clinical Trials 25
Prominent Drugs 26
Latest Clinical Trials News on Hairy Cell Leukemia 27
May 16, 2013: AstraZeneca's MedImmune Enrolls First Patient In Phase III Leukemia Trial Of Moxetumomab Pasudotox 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
AstraZeneca PLC 28
Clinical Trial Overview of AstraZeneca PLC 28
TG Therapeutics, Inc. 29
Clinical Trial Overview of TG Therapeutics, Inc. 29
Jacobus Pharmaceutical Company 30
Clinical Trial Overview of Jacobus Pharmaceutical Company 30
GlaxoSmithKline plc 31
Clinical Trial Overview of GlaxoSmithKline plc 31
Eisai Inc. 32
Clinical Trial Overview of Eisai Inc. 32
Daiichi Sankyo Company, Limited 33
Clinical Trial Overview of Daiichi Sankyo Company, Limited 33
Clinical Trial Overview of Top Institutes / Government 34
National Cancer Institute 34
Clinical Trial Overview of National Cancer Institute 34
Fred Hutchinson Cancer Research Center 37
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 37
City of Hope National Medical Center 39
Clinical Trial Overview of City of Hope National Medical Center 39
The University of Chicago 40
Clinical Trial Overview of The University of Chicago 40
Thomas Jefferson University 41
Clinical Trial Overview of Thomas Jefferson University 41
The University of Texas M. D. Anderson Cancer Center 42
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 42
Northwestern University 43
Clinical Trial Overview of Northwestern University 43
UCLA's Jonsson Comprehensive Cancer Center 44
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 44
Memorial Sloan Kettering Cancer Center 45
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 45
Swiss Group for Clinical Cancer Research 46
Clinical Trial Overview of Swiss Group for Clinical Cancer Research 46
Five Key Clinical Profiles 47
Appendix 63
Abbreviations 63
Definitions 63
Research Methodology 64
Secondary Research 64
About GlobalData 65
Contact Us 65
Disclaimer 65
Source 66

List of Tables
Hairy Cell Leukemia Therapeutics, Global, Clinical Trials by Region, 2014* 7

Full Table of Contents is available at:

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Press Information

Published by
Bill Thompson

# 905 Words
Related Articles
More From Health
New dynamics in monitoring diagnostics in leukemia
Dresden/Germany Diagnosis leukemia and stem cell transplantation The diagnosis "leukemia" for patients means to undergo [..]
PromarkerD Predictive Diagnostics for DKD to Roll-out [..]
PERTH, AUSTRALIA, Mar 22, 2017 - (ACN Newswire) - Proteomics International Laboratories Ltd ('PILL'; ASX: PIQ), a world leader [..]
Do Prostalgene Drops Help To Restore Prostate [..]
Prostate enlargement is among the most common health problems for men over 50. With age the incidence of this condition [..]
Is OnycoSolve Spray The Key To Obliterating [..]
Toenail fungus is an undesirable but stubborn infection that comes with sweating, itching, cracking and scaling of the feet, inflammations, [..]
New Research reveals Asia poised as Preferred [..]
SYDNEY, Mar 10, 2017 - (ACN Newswire) - Frost & Sullivan has released its latest white paper, 'Asia: Preferred Destination for [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.